Premium Information is available for this item - Upgrade for $1 a day
6505-01-155-0513
Usp Dipyridamole Tablets
6505011550513 011550513 NDC00223-0839-02 NDC00879-0467-10 NDC00182-1354-10GENERIX DRUG CO 1275060 NDC00090-4108-48 NDC00781-1478-10
January 2023
5
Marketplace 6505-01-155-0513
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-155-0513 5+ Documents (More...)
/fsg-65/fsc-6505/us
Stock Numbers Related to 6505-01-188-5402 6505-21-870-5071 6505-01-101-5360 6505-01-094-7536 6505-01-155-0513
/fsg-65/fsc-6505/ca
Usp Dipyridamole Tablets 6505011550513 /fsg-65/fsc-6505/us 6505-01-109-9469 Usp Dipyridamole Tablets
Pharmaceuticals Related to 6505-00-764-9014 6505-21-870-5071 6505-01-101-5360 6505-01-094-7536 6505-01-155-0513
01-172-7669 Usp Dipyridamole Tablets 6505011727669 870-5071 6505-01-101-5360 6505-01-094-7536 6505-01-155-0513
Stock Numbers Related to 6505-19-000-0877 6505-21-870-5071 6505-01-101-5360 6505-01-094-7536 6505-01-155-0513
/fsg-65/fsc-6505/us
6505/be 6505-13-113-8636 Dipyridamole Tablets 6505131138636 131138636 101-5360 6505-01-094-7536 6505-01-155-0513
Stock Numbers Related to 6505-01-188-5400 6505-21-870-5071 6505-01-101-5360 6505-01-094-7536 6505-01-155-0513
Restrictions 6505-01-155-0513
6505-01-155-0513 is a Usp Dipyridamole Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-155-0513
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-155-0513
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-155-0513
- Part Number
- Manufacturer
- Status
- NDC00223-0839-02
- Manufacturer
- 21016 - Consolidated Midland Corp (Active)
- Primary Buy
- Primary Buy
- NDC00879-0467-10
- 60964 - Halsey Drug Co Inc (Active)
- Primary Buy
- Primary Buy
- NDC00182-1354-10GENERIX DRUG CO
- 88009 - U S Dept Of Veterans Affairs (Active)
- Primary Buy
- Primary Buy
- 1275060
- 1GB76 - Major Crown Inc (Obsolete)
- Primary Buy
- Primary Buy
- NDC00090-4108-48
- 1GB76 - Major Crown Inc (Obsolete)
- Primary Buy
- Primary Buy
- NDC00781-1478-10
- 59043 - Geneva Pharmaceuticals Inc (Obsolete)
- Primary Buy
- Primary Buy
Datasheet 6505-01-155-0513
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 75.000 Milligrams Dipyridamole Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 1000.000 Tablets
- Special Features [FEAT]
- Coating Feature:Sugar;
Management Data 6505-01-155-0513
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Jun 1983
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 1000 Tt
- 00000001000TT
- K
NATO Stock Numbers Related to 6505-01-155-0513
Freight Information 6505-01-155-0513
6505-01-155-0513 has freight characteristics.. 6505-01-155-0513 has a variance between NMFC and UFC when transported by rail and the description should be consulted.